Primary Care

  • Zika vaccine development expected to last through 2020

    on February 24th, 2017
    FROM AN ACIP MEETING Progress continues to be made on creating a Zika vaccine, but taking any of the current candidates all the way through clinical trials and into production could take another few years, according to the latest information presented at a meeting of the Centers for Disease Control [...]
  • Following infection, semen is Zika’s last refuge

    on February 24th, 2017
    AT CROI SEATTLE (FRONTLINE MEDICAL NEWS) – Zika virus RNA lingered longer in semen than in any other body fluid but was cleared by 95% of men after 3 months, according to investigators from the Centers for Disease Control and Prevention. The findings support the agency’s recommendation that men [...]
  • Spotlight shifts to active treatment for concussions

    on February 23rd, 2017
    The prevailing notion that concussions should be managed solely or primarily with prescribed cognitive and physical rest is shifting. Experts in concussion management are increasingly in agreement that concussion is a much more heterogeneous injury than previously believed, and that “active” app[...]
  • Sarcoidosis doubles hospitalized infection risk

    on February 23rd, 2017
    FROM ANNALS OF THE AMERICAN THORACIC SOCIETY Persons with sarcoidosis were found to have double the risk of hospitalization, compared with age-matched controls in a population-based cohort study that also linked glucocorticoid use with an increased risk of hospitalization in this group. Using data f[...]
  • Well-child care: Steady growth in breadth and content

    on February 22nd, 2017
    Fifty years ago in 1967, the American Academy of Pediatrics published a “Suggested Schedule for Preventive Child Health Care.” It was, in essence, the first periodicity schedule for well-child visits. Described by AAP officials at the time as an “amalgamation of schedules used in various clini[...]
  • Lanadelumab reduced hereditary angioedema attacks by 88%-100%

    on February 22nd, 2017
    FROM THE NEW ENGLAND JOURNAL OF MEDICINE Lanadelumab, a monoclonal antibody that inhibits kallikrein, reduced attacks of hereditary angioedema with C1 inhibitor deficiency by 88%-100% in a small, phase I trial. Hereditary angioedema with C1 inhibitor deficiency is a rare disorder characterized by un[...]
  • Testosterone Trials’ cardiac, cognitive results disappoint

    on February 22nd, 2017
    FROM JAMA AND JAMA INTERNAL MEDICINE Testosterone treatment may have beneficial effects on unexplained anemia or bone density in men with age-related low testosterone, but at the cost of an increase in coronary artery plaque and with no benefit on cognitive function, new research suggests. The resul[...]
  • Gluten-free diets related to high levels of arsenic, mercury

    on February 22nd, 2017
    FROM EPIDEMIOLOGY Individuals who adopt a gluten-free diet are putting themselves at risk for uncommonly high levels of arsenic and mercury, according to the findings of a recent study published in Epidemiology. “Despite [less than] 1% of Americans having diagnosed celiac disease, an estimated 25%[...]
  • Appeals court strikes down doctor gun gag law

    on February 21st, 2017
    An appeals court has struck down a Florida law that banned physicians from asking patients about firearms, ruling that the so-called gun gag law violates doctors’ First Amendment rights. The decision by the 11th U.S. Circuit Court of Appeals enables Florida physicians to once again query patients [...]
  • Pertussis susceptibility estimates call for public health push

    on February 21st, 2017
    FROM THE PEDIATRIC INFECTIOUS DISEASE JOURNAL Estimates of high pertussis susceptibility in infants suggest a need for greater public health efforts to increase DTaP vaccine coverage in children and Tdap coverage in pregnant women, according to results of research by Lana Childs and Robert A. Bednar[...]
  • Collaborative care aids seniors’ mild depression

    on February 21st, 2017
    FROM JAMA A collaborative care model significantly mitigated mild depression in adults aged 65 and older, compared with usual care in the short term, based on data from 705 patients. The findings were published online Feb. 21. “There is limited research about older people with mild depressive diso[...]
  • Oral contraceptive use confers long-term cancer protection

    on February 21st, 2017
    FROM THE AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY New findings from a cohort study with more than 4 decades of follow-up show that, while women who have ever used combined oral contraceptives see an increased risk of breast and cervical cancer, the risk disappears within about 5 years after sto[...]
  • Hope on the horizon for novel antidepressants

    on February 21st, 2017
    EXPERT ANALYSIS FROM THE NPA PSYCHOPHARMACOLOGY UPDATE LAS VEGAS – There remains a great unmet need for more effective and rapidly acting treatments for major depressive disorder, and research is revealing that both new and existing drugs may help, according to one expert. One argument for additio[...]
Back to top